Literature DB >> 12085467

Pneumocystis carinii pneumonia in patients with and without HIV infection.

Jean T Santamauro1, Rashmi Nisha Aurora, Diane E Stover.   

Abstract

Advances in the prevention and treatment of Pneumocystis carinii pneumonia in HIV infected patients have led to a decrease in the incidence and improved outcomes. Pneumocystis carinii pneumonia continues to be problematic in non-HIV infected immunocompromised patients.

Entities:  

Mesh：

Year:  2002        PMID： 12085467     DOI： 10.1007/s12019-002-0047-3

Source DB:  PubMed          Journal:  Compr Ther        ISSN： 0098-8243


  3 in total

1.  High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.

Authors:  Leigh Dini; Mignon du Plessis; John Frean; Victor Fernandez
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

Review 2.  The medication for pneumocystis pneumonia with glucose-6-phosphate dehydrogenase deficiency patients.

Authors:  Ziyu Zhang; Qinhui Li; Xiaoyan Shen; Lankai Liao; Xia Wang; Min Song; Xi Zheng; Yulian Zhu; Yong Yang
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

3.  Pneumocystis Jirovecii (carinii) pneumonia causing lung cystic lesions and pneumomediastinum in non-HIV infected patient.

Authors:  Hazim S Bukamur; Emhemmid Karem; Serag Fares; Mohammed Al-Ourani; Amro Al-Astal
Journal:  Respir Med Case Rep       Date:  2018-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.